-
Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Compared to Contrast-Enhanced Magnetic Resonance Imaging of the Breast at 3 Tesla
Magometschnigg HF, Baltzer P, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1656-65.
IPF 5.217
-
Implementation of Multiparametric Magnetic Resonance Imaging with High-Resolution Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging at 7T Improves the Assessment of Breast Tumors: A Feasibility Study
Pinker K, Baltzer P, Bogner W, Leithner D, Trattnig S, Zaric O, Dubsky P, Bago-Horvath Z, Rudas M, Gruber S, Weber M, Helbich TH
Radiology. 2015 Mar 4:141905. [Epub ahead of print]
IPF 6.214
-
Introduction of an Automated User-Independent Quantitative Volumetric MRI Breast Density Measurement System using the Dixon Sequence: Comparison with Mammographic Breast Density Assessment
Wengert GJ, Helbich TH, Vogl WD, Baltzer P, Langs G, Weber M, Bogner W, Gruber S, Trattnig S, Pinker K
Invest Radiol. 2014 Oct 20. [Epub ahead of print]
IPF 4.453
-
Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance imaging: A Feasibility Study
Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH
Clin Cancer Res. 2014 Jul 1;20(13):3540-9.
IPF 8.192
-
Improved Diagnostic Accuracy with Multiparametric Magnetic Resonance Imaging of the Breast using Dynamic Contrast-Enhanced MRI, Diffusion-weighted Imaging and 3D Proton MR Spectroscopic Imaging
Pinker K, Bogner W, Baltzer P, Gruber S, Bickel H, Brueck B, Trattnig S, Weber M, Dubsky P, Bago-Horvath Z, Bartsch R, Helbich TH
Invest Radiol. 2014 May;49(5):354-62.
IPF 4.453
-
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced MR imaging of the breast at 7T
Pinker K, Bogner W, Baltzer P, Trattnig S, Gruber S, Abeyakoon O, Bernathova M, Zaric O, Dubsky P, Bago-Horvath Z, Weber M, Leithner D, Helbich TH
Eur Radiol. 2014 Apr;24(4):913-20.
IPF 4.338
-
Combined contrast enhanced magnetic resonance and diffusion weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3 T imaging of breast lesions
Pinker-Domenig K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U, Rudas M, Bago-Horvath Z, Weber M, Trattnig S, Bogner W
Eur Radiol. 2013 Jul;23(7):1791-802
IPF 4.338
-
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
Pinker-Domenig K, Bogner W, Gruber S, Bickel H, Duffy S, Schernthaner M, Dubsky P, Pluschnig U, Rudas M, Trattnig S, Helbich TH.
Eur Radiol. 2012 Feb;22(2):322-30. Epub 2011 Sep 14.
IPF 4.338
-
Conspicuity of Breast Cancer according to histopathological type and breast density when imaged by Full-field Digital Mammography compared to Screen-film mammography
Pinker K, Perry N, Vinnicombe S, Shiel S, Weber M
Eur Radiol. 2011 Jan;21(1):18-25. Epub 2010 Aug 4.
IPF 4.338
-
A Combined High Temporal and High Spatial Resolution 3 Tesla MR Imaging Protocol for the Assessment of Breast Lesions: Initial Results
Pinker K, Grabner G, Bogner W, Gruber S, Szomolanyi, Trattnig S, Heinz-Peer G, Weber M, Fitzal F, Pluschnig U, Rudas M, Helbich TH
Invest Radiol. 2009 Sep;44(9):553-8
IPF 4.453
-
Longitudinal evaluation of cartilage composition of MACT over 1 year using dGEMRIC at 3 Tesla
Pinker K, Szomolanyi P, Welsch GC, Mamisch TC, Marlovits S, Stadlbauer A, Trattnig S
AJR Am J Roentgenol. 2008 Nov;191(5):1391-6.
IPF 2.744
-
High-field high-resolution susceptibility weighted magnetic resonance imaging- Improved image quality by addition of contrast-agent and higher field strength in patients with brain tumors
Pinker K, Noebauer-Huhmann IM, Stavrou I, Szomolanyi P, Weber M, Stadlbauer A, Knosp E, Trattnig S
Neuroradiology, 2008 Jan;50(1):9-16 Epub 2007 Sep 18
IPF 2.374
-
Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla- Comparison with standard (1.5T) magnetic resonance imaging and correlation with histopathological findings
Pinker K, Stavrou I, Szomolanyi P, Hoeftberger R, Weber M, Stadlbauer A, Knosp E, Trattnig S
Investigative Radiology. 2007 Jun; 42(6):346-51
IPF 4.338
-
High-resolution contrast-enhanced, susceptibilty-weighted magnetic resonance imaging at 3 Tesla in patients with brain tumors- Correlation with Positron Emission Tomography and histopathological Findings
Pinker K, Noebauer-Huhmann IM, Stavrou I, Hoeftberger R, Szomolanyi P, Karanikas G, Weber M, Stadlbauer A, Knosp E, Friedrich K, Trattnig S
AJNR, 2007 Aug: 28(7):1280-6
IPF 3.675
-
Are cerebral cavernomas truly nonenhancing lesions and thereby distinguishable from arteriovenous malformations? MRI findings and histopathological correlation.
Pinker K, Stavrou I, Knosp E, Trattnig S.
Magn Reson Imaging. 2006 Jun;24(5):631-7. Epub 2006 Feb 13.
IPF 2.022
-
The value of high-field MRI (3T) in the assessment of sellar lesions.
Pinker K, Ba-Ssalamah A, Wolfsberger S, Mlynarik V, Knosp E, Trattnig S.
Eur J Radiol. 2005 Jun;54(3):327-34.
IPF 2.160